Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of AZD5718 after single and multiple ascending doses in healthy Japanese …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• AZD5718 (AZD5718)

Snippet

Sponsor: AstraZeneca | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED